Supplemental perioperative oxygen to reduce surgical site infection after high-energy fracture surgery (OXYGEN study)


Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Supplemental perioperative oxygen (SPO) therapy has been proposed as one approach for reducing the risk of surgical site infection (SSI). Current data are mixed regarding efficacy in decreasing SSI rates and hospital inpatient stays in general and few data exist for orthopaedic trauma patients. This study is a phase III, double-blind, prospective randomized clinical trial with a primary goal of assessing the efficacy of 2 different concentrations of perioperative oxygen in the prevention of SSIs in adults with tibial plateau, pilon (tibial plafond), or calcaneus fractures at higher risk of infection and definitively treated with plate and screw fixation. Patients are block randomized (within center) in a 1:1 ratio to either treatment group (FiO2 80%) or control group (FiO2 30%) and stratified by each study injury location. Secondary objectives of the study are to compare species and antibacterial sensitivities of the bacteria in patients who develop SSIs, to validate a previously developed risk prediction model for the development of SSI after fracture surgery, and to measure and compare resource utilization and cost associated with SSI in the 2 study groups. SPO is a low cost and readily available resource that could be easily disseminated to trauma centers across the country and the world if proved to be effective.

Original languageEnglish
Pages (from-to)S25-S31
JournalJournal of Orthopaedic Trauma
StatePublished - 2017
Externally publishedYes


  • Calcaneus fractures
  • Supplemental perioperative oxygen
  • Surgical site infection
  • Tibial pilon fractures
  • Tibial plateau fractures


Dive into the research topics of 'Supplemental perioperative oxygen to reduce surgical site infection after high-energy fracture surgery (OXYGEN study)'. Together they form a unique fingerprint.

Cite this